Gaudium IVF — 360° view

Gaudium IVF, a company in the Healthcare Service Provider industry, reported revenue of ₹37 crore and net profit of ₹9.41 crore for the September 2026 quarter.

Gaudium IVF (NSE: GAUDIUMIVF) closed at ₹99.57 on 20 Nov 2026. Its market capitalisation is ₹725 crore and it trades at 31.3 times earnings.

Share price
₹99.57 (20 Nov 2026)
Market cap
₹725 Cr (20 Nov 2026)
P/E
31.27 (20 Nov 2026)
Revenue
₹37 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
29.5% (FY26)
ROE
24.6% (FY26)
Book value
₹22.4 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹115.00 / ₹90.27 (20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: GAUDIUMIVF

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.